TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
TransMedics Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$71.60+0.82 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $2.91B
- P/E (TTM)
- 18.6
- Dividend yield
- 0.00%
TransMedics Group, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Net product revenue [Member] | $372.40M | $273.87M | $176.07M | $79.23M | $29.66M | $25.09M | – | – | 61.5% | +36.0% |
| Cost of service revenue | $233.09M | $167.67M | $65.55M | $14.23M | $605.00K | $547.00K | – | – | 38.5% | +39.0% |
| Service Unrelated to OCS Transplant [Member] | $4.10M | $4.40M | $4.90M | – | – | – | – | – | 0.7% | -6.8% |
| OCS Lung net revenue [Member] | – | – | – | – | $10.67M | $6.19M | $8.66M | $5.08M | – | – |
| OCS Heart net revenue [Member] | – | – | – | – | $17.68M | $14.20M | $11.44M | $5.96M | – | – |
| OCS Liver net revenue [Member] | – | – | – | – | $1.91M | $5.25M | $3.50M | $1.98M | – | – |
| Unrelated to OCS Transplant [Member] | – | $4.40M | $4.90M | – | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | $84.04M | $21.86M | $19.24M | $16.25M | $6.54M | – | – |
| United Kingdom | – | – | – | – | – | – | $2.23M | $2.58M | – | – |
| Germany | – | – | – | – | – | – | $1.15M | $1.46M | – | – |
| All Other Countries [Member] | – | – | – | $9.42M | $8.40M | $6.40M | $7.35M | $2.44M | – | – |
| All Other Countries [Member] | – | – | – | – | – | – | $7.35M | $6.47M | – | – |
| All Other Countries [Member] | – | – | – | – | $8.40M | $6.40M | $7.35M | – | – | – |
From the segment and revenue-disaggregation notes of TransMedics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.